Background – Hypertension is the most common chronic disease in France and a major risk factor for cardiovascular and kidney disease, as well as dementia. To mark World Hypertension Day on May 17, 2023, this article provides an overview of the latest French epidemiological data. Method – The results compiled in this overview of HTN in France are drawn from several data sources: two general population surveys (Esteban 2014–2016 and the 2019 Santé publique France Barometer), a survey of a panel of general practitioners, and the National Health Data System. Results – In France, the Esteban study found that nearly 30% of adults had hypertension, corresponding to nearly 17 million people with hypertension. Awareness, treatment, and control of hypertension remain suboptimal in France and have shown no recent improvement, with some indicators even deteriorating. Thus, nearly 6 million adults in France have hypertension without knowing it, and more than 4 million people with hypertension who are receiving treatment do not have their blood pressure under control. While more than 1.6 million adults begin antihypertensive treatment each year, the COVID-19 crisis has had a significant impact, with an 11% decline in these new treatments linked to reduced healthcare utilization. Conclusion – Health policies promoting primary prevention of hypertension, its screening, and its management must be implemented quickly to enable, as in other countries, a favorable trend in indicators related to hypertension and its cardiovascular complications.